Stay updated on Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.

Latest updates to the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page
- Check5 days agoChange DetectedRevision history updated: added v3.4.3 and removed v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedLatest revision on 2026-02-05 (v3.4.2) adds Returned date, Quality Control Review Has Not Concluded, and new study sections such as Adverse Events, Outcome Measures (Results), Baseline Characteristics, and Participant Flow. It also removes the older government funding notice and the prior revision (v3.4.1).SummaryDifference2%

- Check41 days agoChange DetectedA government funding notice banner was added and the revision label updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedThe additions describe UI and versioning details on the history page (Show glossary, Results Submitted, color-coded highlights for additions and deletions, and Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check62 days agoChange DetectedA new revision entry v3.3.4 was added to the history and an older entry v3.3.3 was removed. This update affects only the history log metadata and does not alter study data or page functionality.SummaryDifference0.1%

- Check83 days agoChange DetectedMinor UI updates: added 'Revision: v3.3.3' and removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2', with no impact on study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Semaglutide Once-Daily Tablets in Overweight Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Once-Daily Tablets in Overweight Clinical Trial page.